NCT00126633 Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00121745 Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00116389 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas Status TERMINATED Phase PHASE2
NCT00113256 Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00112697 Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00112658 Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00112580 MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00112528 Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00111904 Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00109941 Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00108875 Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00102700 ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00101907 Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer Status TERMINATED Phase PHASE1
NCT00100815 Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00099294 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00096707 Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00089024 Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00088660 PANVACâ„¢-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen Status UNKNOWN Phase PHASE3
NCT00084383 Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas Status COMPLETED Phase PHASE2